Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Study Phase: N/A
Recruitment Status: Recruiting
Start Date: April 21, 2017
End Date: July 01, 2020
Inclusion Criteria:
- Age ≥ 18 years
- Acute HF as a primary cause of hospitalization
- Hospitalizations for acute HF will be determined by local clinician-investigators but should include the following:
- Symptoms (eg, dyspnea, fatigue), signs (eg, elevated jugular venous pressure, peripheral edema), or laboratory/imaging evidence of HF (eg, pulmonary congestion on chest x-ray, elevated natriuretic peptide levels) during the hospitalization and
- Treatments aimed at acute HF (eg, intravenous diuretics, vasodilators, or inotropes)
- LVEF ≤ 40% based on last local measurement using echocardiography, multigated acquisition scan, computed tomography (CT) scanning, magnetic resonance imaging, or ventricular angiography
- Planned discharge to home or other supported care facility where patients are individually responsible for medication management
Exclusion Criteria:
- Prior heart transplant or current/planned left ventricular assistance device
- Chronic kidney disease requiring dialysis
- Terminal illness other than HF, such as malignancy, or with a life expectancy of less than 1 year as determined by the enrolling clinician-investigator
- Unable to participate in longitudinal follow-up, such as plans to move outside the US in the following year
-
Conditions:
- Heart Failure